Discovery & Development

Women, like men, want good medicines that have been tested in clinical trials involving fair representation of both sexes.

Here, James speaks with Christophe Le Ret from Umicore.

Here, James speaks with Michel Lagarde from Thermo Fischer Scientific (Patheon).

Here, James speaks with Tony van Bijleveld from Thermo Fischer Scientific (Patheon).

The end of “mini me” medicine is over, says Andrew Parker, because we can do better when it comes to pediatric care.

What is the current state of pharma contract development and manufacturing?

Making cancer drugs cheaper and more effective – with a paper “coffee” filter.

What is the current state of pharma contract development and manufacturing?

Valarie Higgins discusses how clinical trials have evolved over the years and the key lessons she has learned while building her career in the industry.

mAbs are an important growth area for the biopharma industry – so we need more effective purification technologies.